(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...
Alaunos Therapeutics (TCRT) said Monday it has dosed the first patient in a phase 1/2 trial of TCR-T cell therapy for patients with solid tumors. The...
Health care stocks were ending well above their intra-day lows this afternoon, with the NYSE Health Care Index falling 1.1% in late trade while the SPDR...
Health care stocks were mostly lower this afternoon, with the NYSE Health Care Index falling 1.8%, while the SPDR Health Care Select Sector ETF (XLV) was...
| Address | 8030 El Rio Street Houston, Texas 77054 |
| Phone | +1.346.355.4099 |
| Number of Employees | 48 |
| Recent SEC Filing | 05/16/2022 8-K |
| Chief Executive Officer & Director | Kevin S. Boyle |
| Executive Vice President-Operations | Eleanor M. de Groot |
| Chief Financial Officer | Timothy M. Cunningham |
| Vice President-Research & Development | Drew Deniger |
| Price Open | $0.48 |
| Previous Close | $0.48 |
| 52 Week Range | $0.41 - 3.73 |
| Market Capitalization | $107.5 M |
| Shares Outstanding | 216.0 M |
| Sector | Health Technology |
| Industry | Biotechnology | Next Earnings Announcement | 08/12/2022 |
| Call Open Interest (1d)* |  |
| Put Open Interest (1d)* | |
| Call Volume (1d)* | |
| Put Volume (1d)* | |
| Put Call Open Interest Ratio (1d)* | |
| Put Call Volume Ratio (1d)* | |
| * Data delayed by up to 15 minutes |
| Price / Earnings | N/A |
| Earnings per Share | -$0.35 |
| Beta vs. S&P 500 | N/A |
| Revenue | $146.0 K |
| Net Profit Margin | -19,786.68% |
| Return on Equity | -98.23% |
| Buy | |
| Overweight | |
| Hold | |
| Underweight | |
| Sell | |
Consensus Recommendation | |
